… of hospitalised adults with COVID-19. This guideline does not address in detail the management
of COVID-19 in … The evidence for the management of COVID-19 is accumulating at an …

Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory
properties. This study evaluates the efficacy and safety of baricitinib in combination …

… of characteristics and outcomes of hospitalised adult COVID-19 patients in both USA and
ex-… strategies of COVID-19. Furthermore, it can be used to raise public awareness of COVID-19’…

… of beneficial effects in hospitalised patients and therefore … of anticoagulation in hospitalised
patients with COVID-19, but … to be standard care for hospitalised COVID-19 patients but that …

… A retrospective analysis of adults ≥ 65 years with confirmed COVID-19 admitted to our
institution between 1 March and 24 April 2020 was performed. Patients were categorised into …

… In this observational cohort study of consecutive adults hospitalised with COVID-19, we …
models for COVID-19. These included models developed specifically for COVID-19, along with …

… of Covid-19 … Covid-19 test results linked to electronic health record (EHR) data. The main
aim of this paper is to describe the changing trends in the Covid-19 case hospitalisation risk (…

… Observational, retrospective, longitudinal study Hospitalised adults with COVID-19 moderate
pneumonia 191 patients February 20, 2020–May 5, 2020. 113 patients treated for 2 weeks …

… sought to establish the long-term effects of Covid-19 following hospitalisation. … of Covid-19
during the acute hospital admission with Covid-19 was classified using the WHO COVID-19 …

… hospitalised patients after this date. We are considering a positive result as a surrogate for …
covid-19 disease which required hospitalisation. For participants with multiple covid-19 tests, …